cover
Contact Name
Raymond Pranata
Contact Email
raymond_pranata@hotmail.com
Phone
+6282112918892
Journal Mail Official
ijc@inaheart.org
Editorial Address
Editorial Office: Heart House, Jalan Katalia Raya No. 5, Kota Bambu Utara West Jakarta, 11430 - Indonesia Telephone: +62 21 5681149, Fax: +62 21 5684220 Email: ijc@inaheart.org
Location
Kota adm. jakarta barat,
Dki jakarta
INDONESIA
Indonesian Journal of Cardiology
ISSN : 28303105     EISSN : 29647304     DOI : -
Core Subject : Health,
Indonesian Journal of Cardiology (IJC) is a peer-reviewed and open-access journal established by Indonesian Heart Association (IHA)/Perhimpunan Dokter Spesialis Kardiovaskular Indonesia (PERKI) [www.inaheart.org] on the year 1979. This journal is published to meet the needs of physicians and other health professionals for scientific articles in the cardiovascular field. All articles (research, case report, review article, and others) should be original and has never been published in any magazine/journal. Prior to publication, every manuscript will be subjected to double-blind review by peer-reviewers. We consider articles on all aspects of the cardiovascular system including clinical, translational, epidemiological, and basic studies. Subjects suitable for publication include but are not limited to the following fields: Acute Cardiovascular Care Arrhythmia / Cardiac Electrophysiology Cardiovascular Imaging Cardiovascular Pharmacotherapy Cardiovascular Public Health Policy Cardiovascular Rehabilitation Cardiovascular Research General Cardiology Heart Failure Hypertension Interventional Cardiology Pediatric Cardiology Preventive Cardiology Vascular Medicine
Articles 13 Documents
Search results for , issue "online first" : 13 Documents clear
Faktor Risiko Pneumonia Paska Operasi Bedah Pintas Arteri Koroner Fadhilah, Vita Karima; Achmad, Chaerul; Afrianti, Rien; Santoso, Prayudi
Jurnal Kardiologi Indonesia Vol 45 No 4 (2024): Online First - Indonesian Journal of Cardiology April-June 2021
Publisher : The Indonesian Heart Association

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.30701/ijc.1789

Abstract

Background: Postoperative pneumonia (POP) is a common infectious complication of coronary artery bypass grafting (CABG), leading to significant morbidity, mortality, and increased healthcare costs. This study found that the prevalence of POP was nearly double that reported in previous studies, underscoring the urgent need to identify specific risk factors. These findings emphasize the importance of local data in refining preventive strategies and improving clinical outcomes in CABG patients. Material and Methods: This is a retrospective cohort study. The subjects comprised patients who underwent CABG procedures at a single institution between June 2020 and June 2024. A logistic regression analysis model for evaluating the risk of POP was established. Results: This study observed a POP rate of 41.7%, significantly exceeding the 2–24% range reported in previous studies. Key risk factors included elevated creatinine levels, eGFR <60 ml/min/1.73 m², and low early postoperative albumin. POP strongly correlated with prolonged hospitalization, with an odds ratio of 13.043 (95% CI: 6.130–27.751, p < 0.0001), underscoring its substantial impact on patient outcomes. Conclusions: The present study delineates renal impairment and hypoalbuminemia postoperative as pivotal risk factors for POP following CABG. It emphasizes the importance of tailored interventions, structured institutional practices, and continuous research to enhance preventive strategies and patient outcomes.
Novel Echocardiographic Parameter Assessing Pulmonary Vascular Resistance in Patient with Acyanotic Congenital Heart Disease Natadikarta, Muhammad Raihan Ramadhan; Cool, Charlotte Johanna; Khalid, Achmad Fitrah; Sukmadi, Norman; Martha, Januar Wibawa
Jurnal Kardiologi Indonesia Vol 45 No 4 (2024): Online First - Indonesian Journal of Cardiology April-June 2021
Publisher : The Indonesian Heart Association

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.30701/ijc.1790

Abstract

Background Pulmonary vascular resistance (PVR) is an important variable in management of acyanotic congenital heart disease. Right heart catheterization (RHC) using impedance catheter remains gold standard for pulmonary vascular resistance (PVR) measurement. The ratio of peak tricuspid regurgitant velocity to the right ventricular outflow tract time-velocity integral (TRVmax/RVOTVTI) was presented as a reliable non-invasive method of estimating PVR. Recently, right ventricular 2-dimensional speckle tracking strain (RVGLS) was proven as a new promising parameter to evaluate PVR. This study performed to examine whether this new non-invasive variable ratio (TRVmax/RVGLS) provides clinically reliable method to determine pulmonary vascular resistance (PVR) obtained by echocardiography. Methods Right-heart catheterization and echocardiographic examination were performed in 56 patients with congenital heart disease. The ratio of TRVmax/RVOTVTI and TRVmax/RVGLS analysis performed using receiver-operating characteristic curve analysis, a cutoff value for the ratio was generated to determine PVR more than 5 WU. Results A TRVmax/RVOTVTI cutoff value of 0.21 provided a sensitivity of 77.1% and a specificity of 81% (CI 81% to 97.5%) and TRVmax/RVGLS cutoff value of -23.16 provided sensitivity of 74.3% and a specificity of 90.5% to determine PVR > 5 WU (CI 79.6% to 98.2%). Conclusions The echocardiography parameter (TRVmax/RVGLS) could serve as a dependable noninvasive method to predict PVR greater than 5 WU in acyanotic congenital heart disease patients.
Collagen-Based Hydrogel Encapsulated Cardiosphere-Derived Cell (CDC): Potential of Stem Cells as Tissue Repair Therapy Post-Acute Myocardial Infarction Evananda, Maria Pramesthi Sabrina; Salim, Albert; Surya, Stevanus Christian; Suastika, Luh Olivia Saraswati
Jurnal Kardiologi Indonesia Vol 45 No 4 (2024): Online First - Indonesian Journal of Cardiology April-June 2021
Publisher : The Indonesian Heart Association

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.30701/ijc.1281

Abstract

Acute myocardial infarction (AMI) is a global health issue that is the leading cause of morbidity and mortality. Post-AMI management currently has therapeutic and side effect limitations, and has not been able to repair damage to myocardial tissue caused by AMI. The development and discovery of therapeutic modalities with the potential for a more optimal therapeutic effect remains a challenge in this post-AMI treatment. The purpose of this literature review is to collect and analyze various sources related to collagen-based hydrogel encapsulated cardiosphere-derived cell (CDC). This literature review is written systematically by gathering library sources from various search engines, such as Google Scholar, PubMed, and Research Gate. According to the findings of the study, CDC has the potential to be used as a post-AMI therapy because it can promote regeneration of the heart, which has lost function as a result of the AMI. To achieve the greatest effect, this modality is administered intracoronary. This modality will be encapsulated with collagen hydrogel, which has a cardioprotective effect, in order to increase the survival and effectiveness of CDC. The use of collagen-based hydrogel encapsulated CDC can provide post-AMI cell regeneration effects comparable to existing modalities while having minimal side effects. Further investigation in larger and more definitive trials is needed to elucidate the potential use of CDC therapy in AMI.
Outcome Analysis and Determinants of Major Adverse Cardiac Events in Young Adults After Coronary Artery Bypass Graft Surgery Who Participated in Early Phase II Cardiac Rehabilitation Program: A single-centre study Radi, Basuni Radi; Intan, Ryan Enast; Dwiputra, Bambang; Desandri, Dwita R; Ambari, Ade Meidian
Jurnal Kardiologi Indonesia Vol 45 No 4 (2024): Online First - Indonesian Journal of Cardiology April-June 2021
Publisher : The Indonesian Heart Association

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.30701/ijc.1727

Abstract

Background: Cardiac rehabilitation (CR) program is proven to reduce mortality risk after coronary artery bypass surgery (CABG). Our study aimed to investigate the determinants of survival in young adult patients after CABG. Method: This was a single-centre, longitudinal study with a survival analysis method from MACE of consecutive patients under 55 years old who underwent CABG and participated in the early phase II CR program between January 2017 and December 2018. The major adverse cardiac events (MACE) rates were determined over a 2-year follow-up time. Cox regression and Kaplan-Meier analysis were used to determine the predictors of the events based on the data registry. Result: 279 patients who fulfilled the inclusion criteria were recruited in this study. MACE happened to 23 (8.45%) of them (3 patients died, 20 patients were hospitalised). Patients who dropped out (12%) from the CR program had a higher risk of developing events (HR 3.86, 95% CI 1.36-10.99). Of those who completed the CR program (245 patients), beta-blocker usage, chronotropic index, resting heart rate, and functional capacity after the CR program independently correlated with MACE. Six-minute walk distance (6-MWD) 376 meters was a significant predictor (p=0.001), with a shorter mean survival time of 6 months. Conclusion: The early phase II CR program after CABG in young adult patients reduced the risk for cardiovascular mortality, major adverse events, and related readmission. It also increased the survival rate and mean survival time for participants who completed the CR program compared to dropouts. Optimum beta blocker medication, chronotropic index, resting heart rate, and functional capacity after the CR program are essential predictors of survival after CABG in young adults.
Effects of High-Intensity Interval Training on Cardiovascular Function and Risk Factors, Functional Impairments, and the Quality of Life in Coronary Artery Disease Patients: A Narrative Review Nazir, Arnengsih; Biben, Vitriana; Gunanegara, Aggi; Clementius, Brandon
Jurnal Kardiologi Indonesia Vol 45 No 4 (2024): Online First - Indonesian Journal of Cardiology April-June 2021
Publisher : The Indonesian Heart Association

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.30701/ijc.1751

Abstract

Background: Coronary artery disease (CAD) causes damage to the cardiovascular system that leads to functional and quality of life (QoL) deterrence. Cardiac rehabilitation (CR) aims to improve cardiorespiratory fitness (CRF) to prevent disease progression and its risk factors. Aerobic exercise (AE) causes different physiological effects depending on the applied intensity. High-intensity interval training (HIIT) is being developed because of better effectivity than moderate-intensity continuous training (MICT). Even so, HIIT has not been prescribed generally. This review aimed to describe the effects of HIIT on cardiovascular function and risk factors, functional impairments, and the QoL. Methods: Articles were searched using PubMed and CINAHL databases with the keywords “high-intensity interval training”, “cardiac rehabilitation”, “exercise-based cardiac rehabilitation”, and “coronary artery disease”. Results: Twenty-two articles were found and used to explain sub-topics. Discussion: HIIT improves ventricular function, LVEF, heart contractility, and endothelial function which further improve systolic and diastolic blood pressure. Improvement in cardiovascular risk factors was better in HIIT compared to AE in lower intensities. Studies recommend HIIT for CAD patients due to significant cardiovascular adaptation in this exercise. Compared to MICT, most studies found that HIIT is better at improving CRF. HIIT also positively affects cognitive and affective functions. Research on the impact of HIIT on functional activity and QoL is still limited. However, one study found no differences in physical activity level and QoL in groups given HIIT or MICT. Conclusion: In CAD patients, HIIT is considered an alternative exercise that is more time-efficient than continuous exercise.
Predictive Value of Bazett-Corrected QTc for Chemotherapy-Induced Cardiotoxicity in Breast Cancer: A Retrospective Cohort Study Lerista, Maria; Soniya, Firinda; Salsabila, Zeta Reihan; Putra, Justian Ananda; Agustine, Vania; Banun, Syahri; Felani, Muhammad Rizky; Puspita, Indah; Tondas, Alexander Edo
Jurnal Kardiologi Indonesia Online First
Publisher : The Indonesian Heart Association

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.30701/ijc.1896

Abstract

Background : Cardiotoxicity remains a major concern in breast cancer patients receiving anthracycline-based chemotherapy. Meanwhile, prolongation of the QTc interval has been associated with an increased risk of torsades de pointes; however, the clinical evidence for its role as a predictor of subclinical cardiotoxicity remains limited. This study aims to evaluate the association between Bazett-corrected QTc and the incidence of subclinical left ventricular dysfunction, as measured by strain echocardiography. Methods : This single-center retrospective cohort study was conducted at Dr. Mohammad Hoesin General Hospital, Indonesia (January 2022–December 2023). Female breast cancer patients aged ≥18 years who received anthracycline or non-anthracycline chemotherapy and completed baseline and third-cycle echocardiography were included. QTc was measured from 12-lead ECGs before and after chemotherapy using Bazett’s formula. Subclinical cardiotoxicity was defined as a >15% relative reduction in global longitudinal strain (GLS) from baseline. Logistic regression and ROC analyses assessed the predictive value of baseline QTcB. Result : In 32 breast cancer patients on anthracycline therapy (mean age 49.5 ± 9.0 years) were analyzed; 59.4% developed subclinical cardiotoxicity. Prolonged baseline QTcB, older age, and obesity were significantly associated with subclinical cardiotoxicity (p < 0.05). In multivariate analysis, QTcB remained an independent predictor (OR = 21.09; 95% CI: 0.979–454.4; p = 0.05). ROC analysis showed moderate discrimination (AUC = 0.717; 95% CI: 0.50–0.92; p = 0.04). Conclusion : Prolonged QTc appears to be a promising predictor of subclinical cardiotoxicity with fair diagnostic accuracy. However, it should be considered alongside other modalities. Further studies with larger populations are needed to control for other risk factors.
The Difference Value of Global Pulse Wave Velocity between Type 2 Diabetic and Non-diabetic Patients with Chronic Coronary Syndrome Fadma Yuliani; Eka Fithra Elfi; Yose Ramda Ilhami; Hirowati Ali
Jurnal Kardiologi Indonesia Online First
Publisher : The Indonesian Heart Association

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.30701/ijc.1667

Abstract

Background: Coronary Heart Disease (CHD) remains a major health issue in Indonesia. CHD could lead to myocardial infarction and sudden death, highlighting the necessity for cardiovascular examination and appropriate management to prevent increased morbidity and mortality rates. One non-invasive method for assessing CHD was measuring arterial stiffness using Global Pulse Wave Velocity (PWVg). This study aimed to assess the difference in PWVg among patients with Chronic Coronary Syndrome (CCS) with or without Type 2 Diabetes (T2DM). Methods: This was an analytical cross-sectional study to evaluate the difference in PWVg values among CCS patients with or without T2DM. The study used data from medical records and elective coronary angiography at the Dr. M. Djamil Teaching Hospital’s cardiac catheterization laboratory, where PWVg was measured by Doppler echocardiography examination of CCS patients from April 2023 to 2024. Normality testing using the Shapiro-Wilk test was performed before analyzing all numerical data, followed by independent t-tests or Mann-Whitney tests to determine intergroup differences. Results: The study comprised 36 CCS patients, with 18 samples per group (with and without T2DM). In this study, males were more prevalent in the CCS group without T2DM, smoking risk factors were more commonly found in the CCS group without T2DM, higher Random Blood Glucose (RBG) was found in the CCS group with T2DM, and higher Ankle-Brachial Index (ABI) values were observed in the CCS group without T2DM. Based on statistical analysis, there was a significant difference in PWVg values between the CCS group with T2DM and the group without T2DM (8.3 + 0.7 m/s vs. 7.7 + 0.5 m/s, p=0.009). Conclusion: T2DM results in higher PWVg values compared to those without T2DM among patients with CCS.
Multifocal Atrial Tachycardia in a 9-Month-Old Infant: A Case Report with Therapeutic Insights Diego Chemello; Camila Sales Fagundes; Patricia Chagas; Leticia Hadlich Correa de Barros; Patricia Rodrigues Lemos Cardoso
Jurnal Kardiologi Indonesia Online First
Publisher : The Indonesian Heart Association

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.30701/ijc.1889

Abstract

Background: Supraventricular tachycardia is the most common arrhythmia in infants, with an estimated prevalence between 1/250 and 1/1000. Multifocal Atrial tTachycardia (MAT), a rare subtype accounting for less than 1% of supraventricular tachycardia in infants and children, is characterized by multiple atrial foci, variable P-wave morphologies, and irregular ventricular response. When incessant, MAT may lead to tachycardia-induced cardiomyopathy and congestive heart failure. This report describes a 9-month-old infant with MAT and left ventricular dysfunction, emphasizing diagnostic challenges and therapeutic strategies Case Illustration: A previously healthy 9-month-old female infant presented for urgent evaluation due to progressive dyspnea and tiredness during breastfeeding, which had begun approximately two months earlier and worsened in the last two weeks. Her mother noted perioral cyanosis during crying and feeding. On examination, she was tachypneic (60 breaths/min), tachycardic (180 bpm), and mildly dehydrated. Transthoracic echocardiography revealed a dilated left ventricle with moderate systolic dysfunction (ejection fraction 35%). A 12-lead electrocardiogram demonstrated multifocal atrial tachycardia with at least three distinct P-wave morphologies and irregular R-R intervals, and Holter monitoring confirmed an incessant pattern (>30% of the day). Three synchronized direct current cardioversion attempts (0.5, 1.0, and 1.23 J/kg) failed to restore sinus rhythm. Intravenous amiodarone was initiated (loading dose 5 mg/kg over 1 hour, followed by 10 mcg/kg/min), later transitioned to oral therapy (5 mg/kg/day). Within 48 hours, sinus rhythm was restored, heart failure symptoms resolved, and follow-up echocardiography showed improved ejection fraction (55%). Propranolol (1 mg/kg/day) and digoxin (5 mcg/kg/day) were added for rate control. The patient was discharged asymptomatic after one week, with no relapse at 6-month follow-up. Conclusions: MAT is a rare cause of supraventricular tachycardia in infants and may be present with congestive heart failure due to tachycardia-induced cardiomyopathy. Incessant forms are typically defined by an arrhythmia burden greater than 30% of the day on Holter monitoring. Failure of direct current cardioversion is a hallmark of MAT, reinforcing the role of pharmacological management. Early recognition and rate and rhythm control with agents such as amiodarone, propranolol, and digoxin can lead to rapid recovery of left ventricular function and an excellent prognosis in infants without structural heart disease.
Aerobic Exercise Only or in Combination with Resistance Exercise Provides a Significant Reduction in Blood Pressure: A Narrative Review Winda Nurhamda; Arnengsih Nazir; Tertianto Prabowo
Jurnal Kardiologi Indonesia Online First
Publisher : The Indonesian Heart Association

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.30701/ijc.1891

Abstract

Hypertension is a major global health concern and a leading risk factor for cardiovascular disease. While pharmacological therapy remains central, lifestyle interventions, particularly Aerobic Exercise (AE), offer a cost-effective, safe, and sustainable strategy for reducing Blood Pressure (BP) and improving cardiovascular health. Evidence indicates AE consistently lowers Systolic Blood Pressure (SBP) more than Diastolic Blood Pressure (DBP), with clinically meaningful reductions in both. This review aimed to synthesize current evidence on the effects of AE, alone or combined with Resistance Training (RT) or dietary interventions, on BP in individuals with hypertension, elucidate underlying mechanisms, identify moderating factors, and evaluate safety considerations. A narrative review of English-language articles published from 2015 to 2025 was conducted via PubMed, including original and review studies, as well as selected textbooks. Keywords included “aerobic exercise”, “exercise”, “hypertension”, “blood pressure”, “coronary artery disease”, and “cardiovascular disease”. Eligible studies were synthesized into themes reflecting acute and chronic exercise responses, combination interventions, mechanistic pathways, influencing factors, and safety. Thirty-four publications (26 original articles, 6 reviews, 2 textbooks) were included. AE alone or combined with RT consistently reduced SBP, with smaller reductions in DBP, whereas the combination with a hypocaloric diet primarily enhanced cardiorespiratory fitness and body composition. Mechanisms include improved endothelial function, autonomic regulation, metabolic efficiency, and anti-inflammatory effects. Effect size was influenced by age, sex, Body Mass Index (BMI), medication use, exercise timing, and vascular stiffness. Safety data indicated high tolerability, minimal adverse events, and strong adherence. AE is a safe and effective non-pharmacological intervention for hypertension, producing clinically significant BP reductions, particularly in SBP. Combining AE with RT or dietary modification offers additional cardiometabolic benefits. These findings reinforce AE as a cornerstone of hypertension management and support its integration into routine clinical practice.
Serum Endothelin-1 Level >2.0 pg/mL associates with High-Risk Duke Treadmill Score among Chronic Coronary Syndrome Patients Muhammad Sarwansyah Putra; Irsad Andi Arso; Ira Puspitawati; Anggoro Budi Hartopo
Jurnal Kardiologi Indonesia Online First
Publisher : The Indonesian Heart Association

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.30701/ijc.1907

Abstract

Background: Chronic coronary syndrome (CCS) contributes to morbidity and increased risk of acute coronary syndrome within 5 years. Duke Treadmill Score (DTS) is the most robust risk stratification based on cardiac exercise stress test, which predicts 5-year survival. Those with high-risk DTS (DTS ≤11) had the least favorable survival. Endothelin-1, a potent vasoconstrictor peptide, affects the 5-year survival in CCS. This study aimed to investigate the association between serum endothelin-1 level and DTS risk stratification among Indonesian patients with CCS. Methods: This was a cross-sectional study that recruited consecutive patients with CCS after Coronary Angiography (CAG). The DTS data were collected from the previous Treadmill Test (TMT) and were classified into high-risk DTS (DTS ≤-11) and low-moderate-risk DTS (DTS >-11). A serum sample for measuring endothelin-1 was withdrawn during CAG and used in the ELISA protocol. A high endothelin-1 level was defined as > 2.0 pg/mL. An association between variables was assessed using statistical analysis (significance at p < 0.05). Results: Eighty subjects were enrolled. Median time interval of TMT and endothelin-1 measurement was 30 days. Mean age was 58.48±8.73 years old, with males predominant (82.5%). Hypertension (71.3%) and previous Acute Coronary Syndrome (ACS) (52.5%) were dominant. The proportion of subjects with high-risk DTS was 52.5%. Median endothelin-1 level was 1.8 pg/mL (range: 0.4 - 6.8 pg/mL). Serum endothelin-1 level > 2.0 pg/mL was observed in 34 subjects (42.5%), of whom 23 (67.6%) had high-risk DTS. There was a significantly increased risk of high-risk DTS in subjects with serum endothelin-1 >2.0 pg/mL (OR 2.97; 95% CI 1.18-7.51; p=0.020). Based on bivariate analysis, two variables, namely hypertension (p=0.052) and history of ACS (p=0.036), were also significantly associated with high-risk DTS. In multivariate analysis, endothelin-1 level >2.0 pg/mL had an adjusted OR of 1.75 (95% CI: 0.60-5.13, p=0.305), indicating no statistically significant independent association with high-risk DTS. Hypertension and a history of ACS had an independent and significant association with high-risk DTS. Conclusion: Among CCS patients, serum endothelin-1 level > 2.0 pg/mL was associated with high-risk DTS from TMT examination. However, this association was not independent, as in hypertension and history of ACS.

Page 1 of 2 | Total Record : 13


Filter by Year

2024 2026


Filter By Issues
All Issue Vol 47 No 2 (2026): April - June, 2026 Vol 47 No 1 (2026): January - March, 2026 Vol 47 No Suppl_A (2026): Abstracts of the 12th Annual Scientific Meeting of the Indonesian Heart Rh Online First Vol 46 No 4 (2025): October - December, 2025 Vol 46 No 3 (2025): July - September, 2025 Vol 46 No 2 (2025): April - June, 2025 Vol 46 No 1 (2025): January - March, 2025 Vol 45 No Suppl_A (2024): Vol 45 No Suppl_A (2024): Abstracts of the 6th Indonesian Intensive & Acut Vol 45 No 4 (2024): Online First - Indonesian Journal of Cardiology April-June 2021 Vol 45 No 3 (2024): July - September, 2024 Vol 45 No 2 (2024): April - June, 2024 Vol 45 No 1 (2024): January - March, 2024 Vol 45 No Suppl_C (2024): Abstracts of the 33rd Annual Scientific Meeting of the Indonesian Heart As Vol 45 No Suppl_B (2024): Abstracts of the 11th Annual Scientific Meeting of the Indonesian Heart Rh Vol 44 No 4 (2023): Indonesian Journal of Cardiology: October - December 2023 Vol 44 No 3 (2023): Indonesian Journal of Cardiology: July - September 2023 Vol 44 No 2 (2023): Indonesian Journal of Cardiology: April - June 2023 Vol 44 No 1 (2023): Indonesian Journal of Cardiology: January - March 2023 Vol 44 No Suppl_A (2023): Abstracts of the 32nd Annual Scientific Meeting of the Indonesian Heart As Vol 44 No Suppl_B (2023): Abstracts of the 10th Annual Scientific Meeting of the Indonesian Heart Rh Vol 43 No 4 (2022): Indonesian Journal of Cardiology: October - December 2022 Vol 43 No 3 (2022): Indonesian Journal of Cardiology: July - September 2022 Vol 43 No 2 (2022): Indonesian Journal of Cardiology: April - June 2022 Vol 43 No Suppl_B (2022): Abstracts of the 6th InaPrevent (2022) Vol 43 No 1 (2022): Indonesian Journal of Cardiology: January - March 2022 Vol 43 No Suppl_C (2022): Abstracts of the 31st Annual Scientific Meeting of the Indonesian Heart As Vol 43 No Suppl_D (2022): Abstracts of the 9th Annual Scientific Meeting of the Indonesian Heart Rhy Vol 43 No Supplement (2022): Abstracts of the 5th Indonesian Intensive and Acute Cardiovascular Care Vol 42 No 4 (2021): Indonesian Journal of Cardiology: October - December 2021 Vol 42 No 3 (2021): Indonesian Journal of Cardiology: July - September 2021 Vol 42 No 2 (2021): Indonesian Journal of Cardiology: April - June 2021 Vol 42 No 1 (2021): Indonesian Journal of Cardiology: January - March 2021 Vol 42 No Supplement (2021): Abstracts of the 5th InaPrevent in Conjunction with the 1st InTension S Vol 42 No Supplement (2021): Abstracts of the 13th Indonesian Society of Interventional Cardiology A Vol 42 No Supplement (2021): Abstracts of the 8th Annual Scientific Meeting of the Indonesian Heart Vol 41 No 4 (2020): Indonesian Journal of Cardiology: October - December 2020 Vol 41 No 3 (2020): Indonesian Journal of Cardiology: July - September 2020 Vol 41 No 2 (2020): Indonesian Journal of Cardiology: April - June 2020 Vol 41 No 1 (2020): Indonesian Journal of Cardiology: Januari - Maret 2020 Vol 41 No Suppl_A (2020): Abstracts of the 29th Annual Scientific Meeting of the Indonesian Heart As Vol 41 No Suppl_B (2020): Abstracts of the 12th Indonesian Society of Interventional Cardiology Annu Vol 40 No 4 (2019): Indonesian Journal of Cardiology: October-December 2019 Vol 40 No 3 (2019): Indonesian Journal of Cardiology: July-September 2019 Vol 40 No 2 (2019): Indonesian Journal of Cardiology: April-June 2019 Vol 40 No 1 (2019): Indonesian Journal of Cardiology: January-March 2019 Vol 39 No 4 (2018): Indonesian Journal of Cardiology: October-December 2018 Vol 39 No 3 (2018): Indonesian Journal of Cardiology: July-September 2018 Vol 39 No 2 (2018): Indonesian Journal of Cardiology: April-June 2018 Vol 39 No 1 (2018): January - March 2018 Vol 39 No 1 (2018): January - March 2018 Vol 39 No Suppl_A (2018): Indonesian Journal of Cardiology Supplement_A Vol 39 No Suppl_B (2018): Indonesian Journal of Cardiology Supplement_B Vol 39 No Suppl_B (2018): Indonesian Journal of Cardiology Supplement_B Vol 39 No Suppl_A (2018): Indonesian Journal of Cardiology Supplement_A Vol 38 No 4 (2017): October - December 2017 Vol 38 No 4 (2017): October - December 2017 Vol 38 No 3 (2017): July - September 2017 Vol 38 No 3 (2017): July - September 2017 Vol. 38, No. 2 April-June 2017 Vol. 38, No. 2 April-June 2017 Vol. 38, No. 1 Januari-Maret 2017 Vol. 37, No. 4 Oktober - Desember 2016 Vol. 37, No. 3 Juli - September 2016 Vol. 37, No. 2 April - Juni 2016 Vol. 37, No. 1 Januari - Maret 2016 Vol. 36, No. 4 Oktober - Desember 2015 Vol. 36, No. 3 Juli - September 2015 Vol. 36, No. 2 April - Juni 2015 Vol. 36, No. 1 Januari - Maret 2015 Vol. 35, No. 4 Oktober - Desember 2014 Vol. 35, No. 3 Juli - September 2014 Vol. 35, No. 2 April - Juni 2014 Vol. 35, No. 1 Januari - Maret 2014 Vol. 34, No. 4 Oktober - Desember 2013 Vol. 34, No. 3 Juli - September 2013 Vol. 34, No. 2 April - Juni 2013 Vol. 34, No. 1 Januari - Maret 2013 Vol. 33, No. 4 Oktober - Desember 2012 Vol. 33, No. 3 Juli - September 2012 Vol. 33, No. 2 April - Juni 2012 Vol. 33, No. 1 Januari - Maret 2012 Vol. 32, No. 4 Oktober - Desember 2011 Vol. 32, No. 3 Juli - September 2011 Vol. 32, No. 2 April - Juni 2011 Vol. 32, No. 1 Januari - Maret 2011 Vol. 31, No. 3 September - Desember 2010 Vol. 31, No. 2 Mei - Agustus 2010 Vol. 31, No. 1 Januari - April 2010 Vol. 30, No. 3 September - Desember 2009 Vol. 30, No. 2 Mei - Agustus 2009 Vol. 30, No. 1 Januari - April 2009 Vol. 29, No. 3 September - Desember 2008 Vol. 29, No. 2 Mei - Agustus 2008 Vol. 29, No. 1 Januari - April 2008 Vol. 28, No. 6 November 2007 Vol. 28, No. 5 September 2007 Vol. 28, No. 4 Juli 2007 Vol. 28, No. 3 Mei 2007 Vol. 28, No. 2 Maret 2007 Vol. 28, No. 1 Januari 2007 Vol. 26, No. 1 Januari - Maret 2002 More Issue